Table 1. Clinical characteristics of patients at diagnosis.
| n | % | |
|---|---|---|
| Overall | 111 | 100 |
| NOS | 42 | 38 |
| AITL | 37 | 33 |
| ALK-negative ALCL | 16 | 14 |
| Intestinal | 7 | 6 |
| Lennert-lymphoma | 1 | 1 |
| NK/T, nasal-type | 5 | 5 |
| Hepatosplenic | 3 | 3 |
| Median age (years) | 49 | |
| range | 23–66 | |
| Sex ratio (male/female) | 67:44 | 60:40 |
| Stage (Ann Arbor) | ||
| I or II | 28 | 25 |
| III or IV | 83 | 75 |
| B symptoms | 64 | 58 |
| AaIPI score | ||
| Low/low intermediate | 44 | 40 |
| High/high-Intermediate | 64 | 58 |
| Unknown | 3 | 3 |
| Elevated LDH | 64 | 58 |
Abbreviations: AaIPI, age-adjusted International Prognostic Index; AITL, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic ALK-negative large cell lymphoma; LDH, lactate dehydrogenase; NOS, not otherwise specified; PTCL, peripheral T-cell lymphoma.